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Available online 30 September 2004The mitochondrial toxin 3-nitropropionic acid (3-NP) has been largely
used to study neurodegenerative disorders in which bioenergetic
defects are implicated. In the present study, we analyzed the molecular
pathways involved in FK506 neuroprotection against cell death
induced by 3-NP, using cultured cortical neurons. 3-NP induced
cytochrome c release and increased caspases -2, -3, -8, and -9-like
activities, although, calpain activity was not significantly affected.
FK506 decreased cytochrome c release and caspase-3-like activity
induced by 3-NP, without changing the activities of other caspases. FK-
506 also decreased the number of apoptotic neurons, determined by
Hoechst. Under these conditions, FK506 alone significantly reduced
calcineurin activity by about 50%. Our results also showed a decrease
in mitochondrial Bax and an increase in mitochondrial Bcl-2 levels
upon exposure to FK506 and 3-NP. However, no significant changes
occurred in total Bcl-2 and Bax levels. Altogether, the results suggest
that FK506 neuroprotection against 3-NP-induced apoptosis is asso-
ciated with the redistribution of Bcl-2 and Bax in the mitochondrial
membrane.
D 2004 Elsevier Inc. All rights reserved.
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Neurodegenerative diseases are thought to be associated with
the impairment of neuronal energy metabolism. Several studies
have reported the occurrence of mitochondrial dysfunction in
brains from Huntington disease (HD) patients, namely, through the
inhibition of respiratory chain complexes II and III (Browne et al.,
1997; Gu et al., 1996). Systemic administration of the mitochon-
drial toxin 3-nitropropionic acid (3-NP), an irreversible inhibitor of0969-9961/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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malities and cortical and striatal neuronal degeneration in rats and
nonhuman primates, similar to that seen in humans with HD (Beal
et al., 1993; Brouillet et al., 1998).
3-NP produces neuronal death secondary to perturbed intra-
cellular calcium homeostasis. In primary rat neuronal cultures, 3-
NP induces a gradual increase in mitochondrial calcium and
reactive oxygen species which are prevented in the presence of
caspase inhibitors (Lee et al., 2002a). At higher concentrations, 3-
NP administration results in a massive elevation of mitochondrial
and cytosolic calcium, a decrease in ATP levels, a rapid
mitochondrial membrane depolarization, and the activation of
calpains (Lee et al., 2002b; Nasr et al., 2003; Pang and Geddes,
1997). Under these conditions, caspase activity is not affected,
which is in agreement with cells undergoing death by necrosis
(Nasr et al., 2003). On the other hand, apoptotic cell death induced
by 3-NP has been largely documented through the analysis of
DNA fragmentation by TUNEL staining, the release of cytochrome
c, the activation of caspase-3, and alterations in the levels of the
apoptosis-related protein markers Bax and Bcl-2 (Kim and Chan,
2001; Rodrigues et al., 2000; Vis et al., 2002).
FK506 has been described to act as a selective inhibitor of
calcineurin (or protein phosphatase 2B) (Griffith et al., 1995; Liu
et al., 1991), a ubiquitously expressed Ca2+/CaM-dependent
protein phosphatase that is a critical component of several Ca2+-
dependent signaling pathways. Calcineurin regulates a number of
transcription factors and ion channels and is involved in long-term
depression of postsynaptic potential and synaptic vesicle recycling
(Crabtree, 2001; Kramer et al., 2003). Calcineurin has been also
implicated in neuronal cell death induced by insults that elevate
cytosolic calcium (Ankarcrona et al., 1996; Agostinho and
Oliveira, 2003; Wang et al., 1999; Wood and Bristow, 1998).
Calcineurin can promote apoptosis through dephosphorylation of
Bad at 112Ser and 136Ser (Wang et al., 1999), a proapoptotic
member of the Bcl-2 family. Dephosphorylated Bad translocates
from the cytosol to the mitochondria where it inhibits antiapop-
totic activity of Bcl-2 and Bcl-xL, ultimately, leading to cell death
(Desagher and Martinou, 2000, for review). In accordance, FK506
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cultures after exposure to glutamate (Ankarcrona et al., 1996; Asai
et al., 1999) or to amyloidogenic peptides (Agostinho and
Oliveira, 2003). FK506 also prevented calcineurin-mediated
dephosphorylation of nitric oxide synthase, leading to neuro-
protection (Dawson et al., 1993; Nishino et al., 1996). In addition,
FK506 was shown to increase the survival of grafted embryonic
dopamine neurons (Castilho et al., 2000). However, the precise
mechanisms of neuroprotection evoked by FK506 are not fully
understood.
Thus, in the present study, we evaluated the protective effect of
FK506 in the apoptotic process induced by the mitochondrial toxin
3-NP. Our results indicate that FK506 prevents 3-NP-induced
cytochrome c release, caspase-3 activation, and DNA fragmenta-
tion by decreasing mitochondrial Bax and increasing mitochondrial
Bcl-2 levels.Materials and methods
Materials
Neurobasal medium and B-27 supplement were purchased from
GIBCO (Paisley, UK). The protease inhibitor cocktail (chymosta-
tin, pepstatin A, leupeptin, and antipain), penicillin/streptomycin,
N-acetyl-Ile-Glu-Pro-Asp-p-nitroanilide (Ac-IEPD-pNA), nigeri-
cin, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), and 3-nitropropionic acid were from Sigma Chemical Co.
(St. Louis, MO, USA). FK506, Streptomyces sp. (Tacrolimus), N-
acetyl-Asp-Glu-Val-Asp-p-nitroanilide (Ac-DEVD-pNA), and
Calcineurin Cellular Activity Assay Kit were obtained from
Calbiochem (Darmstadt, Germany). N-acetyl-Val-Asp-Val-Ala-
Asp-p-nitroanilide (Ac-VDVAD-pNA) and N-acetyl-Leu-Glu-
His-Asp-p-nitroanilide (Ac-LEHD-pNA) were from BioSource
International, Inc. (Nivelles, Belgium). N-succinyl-Leu-Leu-Val-
Tyr-AMC (Suc-LLVY-AMC) was from Bachem (Bubendorf,
Switzerland). Primary antibodies anti-cytochrome c, anti-Bad,
anti-a-tubulin, and anti-Bcl-2 and anti-Bax were from PharMingen
(San Diego, CA, USA), Transduction Laboratories (Lexington,
UK), Zymed Laboratories Inc. (San Francisco, CA, USA), and
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA), respec-
tively. The antibody against a-spectrin, mAb 1622, was obtained
from Chemicon (Temecula, CA). Acetoxymethyl ester of BCECF,
2V,7V-bis-(carboxyethyl)-5(and-6)carboxyfluorescein (BCECF-
AM) and Hoechst 33342 were from Molecular Probes (Eugene,
OR, USA). All other reagents were of analytical grade.
Cell culture
Cortical neurons were isolated from 15- to 16-day-old Wistar
rat embryos, and the cortical tissues were loaded in Krebs medium
(in mM: 120.9 NaCl, 4.8 KCl, 1.2 KH2PO4, 25.5 NaHCO3, 13
glucose, 10 HEPES, pH 7.4) containing 0.3% BSA, 0.05% trypsin,
and 0.04 mg/ml DNase for 10 min at 378C. The reaction was
stopped by addition of the same volume of Krebs medium
containing 0.3% BSA, 0.075% trypsin inhibitor and 0.04 mg/ml
DNase. This solution was removed after centrifugation (180  g,
for 5 min), and the cells were dissociated in a new Krebs medium.
After removal of the latter solution, the neurons were resuspended
in neurobasal medium supplemented with 2% B-27, 0.2 mM
glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin andcultured in a humidified incubator at 378C (95% air and 5% CO2).
Cortical cultures contained few glial cells (less than 10%) as
assessed by immunofluorescence using anti-MAP2 (microtubule-
associated protein) and anti-GFAP (glial fibrillary acidic protein)
(not shown).
Neurons isolated from the cortex were cultured for 3–6 days
and then incubated with 0.1–10 mM 3-NP for 24 h. Before
incubation with 3-NP, some cells were pretreated with 1 AM
FK506 for 20–30 min. Stock 3-NP solution was dissolved in water
and brought to pH 7.4 with NaOH. Stock solutions of FK506 were
prepared in DMSO.
Analysis of cell viability
MTT assay
The reduction status of the cells were measured by a
colorimetric assay for cell survival, using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT), according to the
method described by Mosmann (1983). MTT (0.5 mg/ml) in Na+
medium (in mM: 132 NaCl, 1.2 NaH2PO4, 1.4 MgCl2, 4 KCl, 10
HEPES, 6 glucose, and 1 CaCl2, pH 7.4) was added to the cultures
and incubated for 2 h at 378C in the dark. When taken up by living
cells, MTT is converted to a water-insoluble blue product
(formazan). The precipitated dye was dissolved in 0.04 M HCl
in isopropanol and colorimetrically quantitated (absorbance at
570 nm). Values were expressed as the percentage of optical
density of control cells, in the absence of 3-NP or FK506.
Lactate dehydrogenase (LDH) measurements
The integrity of the plasma membrane was determined by
monitoring the activity of the cytoplasmic enzyme LDH in the
extracellular incubation medium, which represents a common
procedure to determine membrane leakage and cellular damage.
Assessment of intracellular LDH was determined after lysing the
cells with 10 mM HEPES (pH 7.4) plus 0.01% Triton X-100 and
freezing at 808C. Cell debris in both aliquots (intracellular and
extracellular) were removed by centrifugation at 14,000 rpm
(Eppendorf Centrifuge 5417R), for 10 min. LDH activity was
determined spectrophotometrically (Perkin-Elmer Lambda-2), by
following the rate of conversion of reduced nicotinamide adenine
dinucleotide (NADH) to oxidized nicotinamide adenine dinucleo-
tide (NAD+) at 340 nm, according to the method of Bergmeyer and
Bernt (1974). LDH released into the extracellular medium was
expressed as a percentage of the total LDH activity in the cells [%
of LDH released = extracellular LDH/(extracellular LDH +
intracellular LDH)].
Intracellular pH measurements
Measurement of intracellular pH (pHi) was assessed by
following the changes in fluorescence of the pH-sensitive probe
2V,7V-bis-(carboxyethyl)-5(and-6)carboxyfluorescein (BCECF)
similarly as described by Rego and Oliveira (1998). Cortical cells
were loaded with 5 AM BCECF-AM for 45 min, at 378C, in culture
medium, in an atmosphere of 95% air and 5% CO2, to avoid major
changes in cellular pH. Loaded cells were further incubated for
20 min in cultured medium without the probe to allow hydrolysis
of the acetoxymethyl ester. The cells were rinsed, and fluorescence
signals were monitored for 10 min in Na+ medium, with double
excitation at 440 and 490 nm and emission at 530 nm, by using a
temperature-controlled SPEX Fluorolog spectrometer. The fluo-
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medium (identical with the Na+ medium, except that NaCl was
replaced with 132 mM KCl) containing 10 AM nigericin, a K+/H+
ionophore. A calibration curve of fluorescence versus pH was
constructed by changing the pH (6.0 to 8.0) of the K+ medium on
different coverslips.
Calcineurin activity assay
Calcineurin activity was assessed using Calcineurin Cellular
Activity Assay Kit, according to the manufacturer’s instruction.
Briefly, the phosphopeptide derived from the RII subunit of cAMP-
dependent kinase (RII phosphopeptide  DLDVPIPGRFDRRVpS-
VAAE), a well-known substrate for calcineurin, was used as the
substrate. Cortical neurons were lysed in lysis buffer (50 mM Tris–
HCl (pH 7.5), 1 mM DTT, 100 AM EDTA, 100 AM EGTA, 0.2%
NP-40). After removal of free phosphate, the lysate was incubated
with RII phosphopeptide (1.64 mg/ml) in assay buffer containing
100 mM NaCl, 50 mM Tris–HCl (pH 7.5), 6 mM MgCl2, 0.5 mM
DTT, 0.025% NP-40 with 0.5 mM CaCl2 or with 10 mM EGTA.
After 30 min at 308C, reactions were terminated by adding 100 Al
GREENk reagent, and absorbance was measured at 620 nm using
a 96-well plate reader (SLT.SPECTRA).
Caspase protease activity assay
Caspases-like activities were determined according to mod-
ifications of the method described by Cregan et al. (1999). After
the incubation period, the culture media were removed, and cells
were washed in PBS. The lysis buffer (in mM: 25 HEPES,
2 MgCl2.6H2O, 1 EDTA, 1 EGTA, pH 7.4) supplemented with
1 mM 1,4-dithiotreitol (DTT), 1 mM phenylmethylsulfonyl
fluoride (PMSF), and 1:1000 protease inhibitor cocktail (chymos-
tatin, pepstatin A, leupeptin, and antipain, 1 mg/ml) was added to
cells, on ice. Cortical cell lysates were frozen three times in liquid
N2 and centrifuged (14,000 rpm, for 10 min, Eppendorf
Centrifuge 5417R). The resulting supernatants were assayed for
protein content by the Sedmak method (Sedmak and Grossero,
1977). To measure caspase activity, 25–65 Ag of protein was
added to a reaction buffer [25 mM HEPES, 10% (m/v) sucrose,
0.1% (m/v) 3-[(3-cholamidopropyl) dimethylammonio]-1-pro-
pane-sulfonate (CHAPS), pH 7.5] containing the colorimetric
substrates (100 AM) for caspase-2 (Ac-VDVAD-pNA), caspase-3
(Ac-DEVD-pNA), caspase-8 (Ac-IETD-pNA), or caspase-9 (Ac-
LEHD-pNA)-like activities. The reaction mixtures were incubated
at 378C for 2 h, and the formation of pNA was measured at 405
nm using a 96-well plate reader (SLT.SPECTRA). Caspases-like
activities were calculated as the increase above the control for
equal protein loaded.
Calpain activity assay
Calpain activity was assessed by measuring the hydrolysis of
7-amino-4-methyl-coumarin (AMC) dye from the C terminus of
the peptide substrate N-succinyl-Leu-Leu-Val-Tyr-AMC (Suc-
LLVY-AMC). Cortical cells were loaded in Na+ medium
containing 80 AM Suc-LLVY-AMC, and fluorescence signals
were monitored for 1 h, with excitation at 380 nm and emission
at 460 nm, by using a temperature-controlled SPEX Fluorolog
spectrometer. As a negative control, fluorescence was measured
under the same conditions using Na+ medium without calciumand containing 10 mM EGTA. To calculate the relative calpain
activity, the rate of increase in fluorescence was normalized to
control activity, which was set at 1.
Nuclear morphology assay
The nuclear morphology of cortical neurons was analyzed by
fluorescence microscopy of living cells using Hoechst 33342 dye.
After incubation for 24 h, the medium was replaced by new
neurobasal medium, and the cortical neurons remained in culture
for an additional 24 h (without FK506 or 3-NP). Then, cells were
washed briefly in phosphate buffer (PBS, in mM: 137 NaCl,
2.7 KCl, 1.4 K2HPO4, 4.3 Na2HPO4, pH 7.4), fixed in 4%
paraformaldehyde (pH 7.4) for 10 min and incubated with 7.5 Ag/
ml Hoechst dye for 10 min. After washing twice in PBS, the
coverslips were fixed to glass slide with mounting medium.
Fluorescence of stained chromatin was examined and scored with a
Nikon Diaphot TMD microscope (Nikon Corporation, Tokyo,
Japan), using a triple XF-63 Omega filter (Omega Optical Inc.,
Brattleboro, VT, USA).
Western blotting analysis
The culture medium was removed, and cells were washed in
ice-cold sucrose buffer, containing (in mM): 250 sucrose, 20
HEPES/KOH (pH 7.4), 1 EGTA, and 1 EDTA. The cells were
extracted in sucrose buffer supplemented with 1 mM DTT, 1 mM
PMSF, and 1:1000 protease inhibitor cocktail, on ice. Lysates
were homogenized and centrifuged (48C) at 500  g for 12 min
to pellet the nucleus and cell debris. The supernatant (total
fraction) was further centrifuged at 12,000  g for 20 min. The
resulting pellet (mitochondrial fraction) was resuspended in
supplemented sucrose buffer. TCA 15% was added to the
supernatant and centrifuged at 15,800  g for 10 min. The
resulting pellet (cytosolic fraction) was resuspended in supple-
mented sucrose buffer and brought to pH 7 with KOH. Protein
content was determined by the method of Sedmak and Grossero
(1977), and samples were frozen at 808C. Equivalent amounts
of protein were separated on a 6.5–15% SDS–PAGE gel and
electroblotted onto polyvinylidene difluoride (PVDF) membranes
(Amersham). After blocking with 5% skim milk in TBS (25 mM
Tris–HCl, pH 7.6, 150 mM NaCl)/0.1% Tween, for 2 h (RT),
the membranes were incubated with the antibodies directed
against the denatured form of cytochrome c (1:500), Bad
(1:250), Bax (1:250), Bcl-2 (1:500), or a-spectrin (1:2500),
overnight at 48C. The membranes were further incubated with
the secondary mouse antibody (1:20,000), and the proteins were
visualized by using an enhanced chemifluorescence reagent
(Amersham Biosciences, Buckinghamshire, UK). The antibody
directed against a-tubulin (1:1000) was used to normalize the
amount of protein per lane.
Statistical analysis
Data are expressed as mean F SEM of the number of
experiments indicated in the figure legends. Comparisons among
multiple groups were performed with a one-way analysis of
variance (ANOVA) followed by a Tukey-Kramer post hoc test.
Comparisons between two groups were achieved with Student
t test (GraphPad Prism Version 3.0). Significance was accepted
at P b 0.05.
Table 2
Intracellular pH upon exposure to 3-nitropropionic acid
pHi pHe
Control 6.99 F 0.15 7.31 F 0.013
3-NP
2 mM 6.88 F 0.19 7.31 F 0.024
3 mM 7.01 F 0.43 7.31 F 0.011
6 mM 7.00 F 0.05 7.34 F 0.012
10 mM 6.29 F 0.15* 7.33 F 0.050
Intracellular pH (pHi) was measured after incubation with 2–10 mM 3-NP
for 24 h. pHi was determined in cortical neurons loaded with 5 AMBCECF-
AM for 45 min at 378C. The neurons were further incubated for 20 min in
the absence of the probe. Fluorescence (ratio 490/440 nm) was measured in
Na+ medium at pH 7.4. Calibration of fluorescence was performed in K+
medium (132 mM KCl), in the presence of 10 AM nigericin. Extracellular
pH (pHe) was measured at the end of each experiment. Data, obtained after
10-min fluorescence measurement, are the means F SEM of 4–10 separate
experiments, run in duplicates.
* P b 0.05 compared to the control.
S. Almeida et al. / Neurobiology of Disease 17 (2004) 435–444438Results
FK506 prevents mitochondrial cytochrome c release induced by
3-NP
We first analyzed the changes in cell viability and intracellular
pH after exposure of primary cultured cortical neurons to
increasing concentrations of 3-NP, a neurotoxin known to
irreversibly inhibit mitochondrial complex II (Coles et al.,
1979). The reducing capacity of the cells, determined using the
MTT assay, was dose-dependently decreased in the presence of 3-
NP, as shown in Table 1. Incubation of cultured neurons with 0.1
and 0.3 mM 3-NP decreased MTT reduction by about 7.7% and
16.5%, respectively, whereas 1–10 mM 3-NP decreased MTT
reduction by 30–50%, suggesting a massive loss of cell-reducing
capacity. The integrity of the plasma membrane was also analyzed
by following the LDH leakage. Exposure of cells to 0.1 and 0.3
mM 3-NP did not significantly alter LDH leakage, compared to
the control (untreated neurons) (Table 1). However, in the
presence of 1–10 mM 3-NP, the release of LDH was significantly
increased. These data show that the cell-reducing status is affected
under 3-NP concentrations that do not alter the integrity of the
plasma membrane. To determine if any changes in intracellular pH
(pHi) could account for the loss of cell viability in the presence of
3-NP, we used the pH-sensitive probe BCECF to verify the pHi
upon incubation with increasing 3-NP concentrations (2 to 10
mM). With the exception of a significant reduction in pHi in
neurons exposed to 10 mM 3-NP, no other changes were observed
(Table 2). Furthermore, and as expected, extracellular pH (pHe),
measured at the end of each experiment, was not significantly
changed.
Data shown in Table 1 indicated that 0.1–0.3 mM 3-NP was
not associated with a massive necrotic cell death, as no
significant changes in cell viability, determined by LDH leakage,
were observed. Under these conditions, we analyzed the levels of
mitochondrial and cytosolic cytochrome c by Western blotting.
Control cells exhibited almost undetectable levels of cytosolic
cytochrome c (Fig. 1). In contrast, there was a significant
accumulation of cytochrome c in the cytosol after incubation of
cells with 0.3–3 mM 3-NP (Fig. 1B), whereas mitochondrialTable 1
Analysis of changes in cell viability induced by 3-nitropropionic acid
MTT reduction (% of control)
FK506 +FK506 (1AM
Control 100.0 F 0.19 105.4 F 4.26
3-NP
0.1 mM 92.32 F 1.22** 94.18 F 5.33
0.3 mM 83.46 F 2.61** 88.03 F 1.80
1 mM 70.19 F 1.93*** 77.64 F 0.94
3 mM 66.26 F 3.71*** 70.10 F 1.73
10 mM 52.02 F 1.05*** 61.37 F 0.07
Cortical neurons were pretreated with 1 AM FK506 and incubated in the absence o
cells was analyzed by measuring the reduction of the tetrazolium salt MTT to form
the control (untreated neurons). The integrity of the plasma membrane was determ
of NADH to NAD+ at 340 nm. LDH released into the extracellular medium was
were expressed as the means F SEM of three to seven experiments, performed i
* P b 0.05, compared to untreated neurons.
** P b 0.01, compared to untreated neurons.
*** P b 0.001, compared to untreated neurons.
# P b 0.05, compared to 3-NP-treated neurons in the absence of FK506.cytochrome c was reduced by about 30% (P b 0.01) (Fig. 1A).
Next, we evaluated whether FK506 (1 AM), a selective inhibitor
of calcineurin (Griffith et al., 1995; Liu et al., 1991), prevents
mitochondrial cytochrome c release induced by 3-NP (0.3 mM).
We observed that FK506 prevented the release of cytochrome c,
decreasing cytosolic levels to control values (P b 0.01) (Figs.
1C, D). Under these conditions, both cellular reduction capacity
and the integrity of the plasma membrane were not significantly
affected by exposure to FK506 in the presence of 3-NP (Table
1).
Given that FK506 is a selective inhibitor of calcineurin (Griffith
et al., 1995; Liu et al., 1991), we also examined the changes in
calcineurin activity induced by FK506 and 3-NP. We observed that,
although FK506 (1 AM) significantly decreased calcineurin activity
(approximately 50%, P b 0.05), no change in calcineurin activity
was observed upon exposure of cortical neurons to 0.3 mM 3-NP
alone (Fig. 2). However, FK506 greatly reduced calcineurin
activity in 3-NP-treated neurons (approximately 60%, P b 0.05,
vs. 3-NP-treated neurons). Changes in calcineurin activity due to
exposure to FK506, in the absence or in the presence of 3-NP, were
not significantly different.LDH leakage (% of total)
) FK506 +FK506 (1AM)
23.48 F 2.04 26.99 F 4.18
26.65 F 3.97 26.63 F 2.80
27.19 F 2.99 31.46 F 5.23
# 32.10 F 2.52* 26.97 F 3.89
32.02 F 2.25* 34.87 F 1.16
# 39.43 F 8.58* 34.63 F 9.66
r in the presence of 0.1–10 mM 3-NP for 24 h. The reduction capacity of the
azan. These results were expressed as the % of optical density observed in
ined by monitoring the leakage of LDH by following the rate of conversion
expressed as a percentage of the total LDH activity in the cells. The results
n duplicates.
Fig. 1. FK506 prevents mitochondrial cytochrome c release induced by 3-NP. (A, B) Cortical neurons were incubated in the absence or presence of 0.3–3 mM
3-NP for 24 h. (C, D) Cortical neurons were pretreated with 1 AM FK506 for 20 min and then incubated in the absence or presence of 0.3 mM 3-NP for 24 h.
Cytochrome c (Cyt c) content in cytosolic (B, D) and mitochondria-enriched fractions (A, C) was detected as a 15-kDa band by Western blot analysis. (Blots)
Representative experiment from three to six different experiments producing the same results. (Graphs) Densitometric analysis of Cyt c upon normalizing Cyt c
signal to the a-tubulin band. Data were expressed as the mean F SEM of three to six different experiments. Statistical analysis: *P b 0.05, **P b 0.01,
compared to untreated neurons; #P b 0.05, ##P b 0.01, compared to 3-NP-treated neurons in the absence of FK506.
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to 3-NP
The release of cytochrome c can precede and/or follow the
activation of several caspases. Therefore, we next determined the
activation of caspases -2, -3, -8, and -9 upon exposure of cells to
increasing concentrations of 3-NP. We further determined whether
FK506 prevents 3-NP-induced caspases activities. As shown in Fig.
3, all the caspases were dose-dependently activated by 3-NP.
Caspases-2 and -9-like activities increased significantly in the
presence of 1–3 mM 3-NP, but not in the presence of a lower
concentration of 3-NP (0.3 mM) (Figs. 3A, D). An increase inFig. 2. Effect of 3-NP and FK506 on calcineurin activity. Cortical cultures
were pretreated with 1 AM FK506 and then incubated in the absence or in
the presence of 0.3 mM 3-NP for 24 h. Cell lysates prepared from collected
neurons were assayed for calcineurin activity as described in Materials and
methods. Data were expressed as the mean F SEM of three different
experiments. Statistical analysis: *P b 0.05, compared to untreated neurons;
#P b 0.05, compared to 3-NP-treated neurons in the absence of FK506.caspase-8-like activity was observed in the presence of 3 mM 3-NP
(P b 0.05) (Fig. 3C). In contrast, caspase-3-like activity was
increased significantly in the presence of all concentrations tested
(Fig. 3B). FK506 (1 AM) completely prevented caspase-3-like
activity induced by 3-NP in the presence of 0.1 (P b 0.05) or 0.3 mM
3-NP (P b 0.01), but not in the presence of 1 or 3 mM 3-NP (Fig.
3B). Nevertheless, FK506 did not significantly prevent the increase
in the activities of caspases-2, -8, or -9 (Figs. 3A, C, D).
As reported previously (Bizat et al., 2003; Nasr et al., 2003), 3-
NP-induced cell death can involve the activation of both caspases
and calpains. To examine the mechanism(s) underlying cortical
neuronal degeneration induced by 3-NP, we studied the breakdown
pattern of fodrin (nonerythroid a-spectrin), a sensitive substrate of
both calpains and caspase-3. The antibody used recognizes the
carboxy terminus of a-spectrin. Calpain-mediated cleavage of
fodrin leads to 150- and 145-kDa doublet, whereas caspase-3-
mediated cleavage results in breakdown products of 150 and
120 kDa. As shown in Fig. 4A, a specific caspase-3-dependent
cleavage of fodrin, leading to accumulation of the 150- and 120-
kDa products, was detected in the presence of 0.3–3 mM 3-NP.
Moreover, the intensity of the 150- and 120-kDa bands increased in
a dose-dependent manner. These results are in agreement with that
shown in Fig. 3B. A 145-kDa breakdown product, indicative of
calpain activity, was only slightly detected upon treatment with 3
mM 3-NP (Fig. 4A).
To assess the proteolytic activity of calpains, we measured the
cleavage of Suc-LLVY-AMC, a fluorogenic substrate cleaved by
calpains (Sasaki et al., 1984). However, no significant changes in
calpain activity were observed in the presence of increasing
concentrations of 3-NP (Fig. 4B).
Effect of FK506 on nuclear fragmentation/condensation
As a means to evaluate cells entering into apoptosis due to
caspase-3 activation, we next analyzed the nuclear morphology of
Fig. 3. Effect of FK506 on 3-NP-mediated activation of caspases-2, -3, -8, and-9. Cortical neurons were pretreated with 1 AM FK506 and further incubated in
the absence or presence of 0.1–3 mM 3-NP for 24 h. Caspase-2 (A), caspase-3 (B), caspase-8 (C), or caspase-9 (D)-like activities were measured by following
the cleavage of the colorimetric substrates Ac-VDVAD-pNA, Ac-DEVD-pNA, Ac-IEPD-pNA, or Ac-LEHD-pNA, respectively. The activity was expressed as
the increase of optical density values above the control (untreated neurons). The results were expressed as the mean F SEM of 3–10 distinct experiments.
Statistical analysis: *P b 0.05, **P b 0.01, ***P b 0.001, compared to the respective control; #P b 0.05, ##P b 0.01, compared to 3-NP-treated neurons in the
absence of FK506.
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without stimuli. Control cells showed about 19.5% F 1.2%
apoptotic cells, with condensed and/or fragmented chromatin
(Fig. 5). In the presence of 0.3–3 mM 3-NP, the number of
neurons displaying condensed and/or fragmented chromatin
increased in a dose-dependent manner: 0.3 mM 3-NP decreased
about 16.5% F 1.8% (P b 0.01) the number of viable cells,
relatively to the control (untreated neurons), whereas 1 and 3 mM
3-NP decreased about 25.0% F 4.2% (P b 0.001) and 29.2% F
0.1% (P b 0.001) the number of viable cells, respectively. Under
these conditions, FK506 prevented 3-NP-induced apoptotic mor-Fig. 4. Effect of 3-NP on calpain activity. Cortical neurons were incubated in the ab
from cortical neurons were analyzed by SDS–PAGE followed by Western blot
cleavage of fodrin leads to 150- and 145-kDa doublet, whereas caspase-3-mediated
dependent proteolytic activity was measured by following the cleavage of the f
increase of fluorescence arbitrary units values above the control (untreated neu
experiments performed in duplicates or triplicates.phology in the presence of 0.3 mM 3-NP (P b 0.05), but not in the
presence of 1–3 mM 3-NP (Fig. 5). These data appear to be in
accordance with FK506-mediated prevention of caspase-3 activity
induced by 3-NP (Fig. 3B).
FK506 decreases Bax and increases Bcl-2 in the mitochondria
Our results suggested that FK506 modulates 3-NP-induced
apoptosis by preventing cytochrome c release and activation of
the apoptotic cascade. Therefore, to further characterize the
mechanism by which FK506 prevents 3-NP-induced apoptosis,sence or presence of 0.3–3 mM 3-NP for 24 h. (A) Total fractions prepared
for fodrin (known substrate of calpain and caspase-3). Calpain-mediated
cleavage results in breakdown products of 150- and 120-kDa. (B) Calpain-
luorogenic substrate Suc-LLVY-AMC. The activity was expressed as the
rons). The results were expressed as the mean F SEM of three distinct
Fig. 5. Effect of FK506 on 3-NP-mediated apoptotic morphology. The
cells were pretreated with 1 AM FK506 and further exposed to 3-NP (0.3–
3 mM) for 24 h. After incubation, the medium was replaced by new
neurobasal medium and the cortical neurons remained in culture for more
24 h (without FK506 or 3-NP). Fixed cells were labeled with Hoechst
33342 dye and assayed for nuclear morphology. Cell viability was
expressed as a percentage of the total number of cells (approximately 100
cells per field were counted). Results were expressed as the mean F SEM
of four distinct experiments, performed in duplicates. Statistical analysis:
**P b 0.01, ***P b 0.001, compared to untreated neurons; #P b 0.05,
compared to 3-NP-treated neurons in the absence of FK506.
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Bcl-2 family proteins in the mitochondria. We analyzed the levels
of Bad, Bax, and Bcl-2 by Western blot in whole cell lysates and
in mitochondria-enriched fractions prepared from cortical cul-
tures. As observed in Figs. 6A, C, E, 0.3 mM 3-NP alone did not
produce any significant alteration in mitochondrial levels of Bad,
Bax, or Bcl-2. However, a significant decrease in mitochondrial
Bax levels (62.0% F 4.7%, P b 0.001) (Fig. 6C) and a
significant increase in mitochondrial Bcl-2 levels (216.9% F
42.6%, P b 0.01) (Fig. 6E) were observed in the presence of
FK506 and 3-NP. Interestingly, mitochondrial Bad levels were not
significantly altered in the presence of 3-NP and FK506 (Fig.
6A). Under these conditions, Bad, Bax, and Bcl-2 levels on
whole cell lysates remained unchanged (Figs. 6B, D, F),
suggesting no major modifications in the expression of these
proteins.Discussion
In the present study, we showed that FK506 prevented
mitochondrial-dependent apoptotic cell death induced by 3-NP.
The calcineurin inhibitor highly prevented cytochrome c release,
caspase-3 activation, and apoptotic nuclei morphology. This
protective effect was related to a decrease in mitochondrial Bax
and an increase in mitochondrial Bcl-2. However, these alterations
were not accompanied by changes of Bad levels in the
mitochondria.
Several in vitro studies have established that 3-NP exposure
induces both apoptosis and necrosis in striatal, cortical, and
hippocampal cells (Behrens et al., 1995; Pang and Geddes, 1997).
The balance between the two types of cell death depends mainly
on the severity of ATP depletion (Eguchi et al., 1997; Leist et al.,
1997; Ohgoh et al., 2000) which is closely related with the dose
and time of exposure to this toxin. In general, low doses of 3-NPinduce less damage and an apoptotic-like cell death, while higher
doses result in acute injury and necrosis (Vis et al., 2002). Our
results showed that low doses of 3-NP (b1 mM) activate caspase-
3 and lead to DNA fragmentation, without affecting plasma
membrane integrity, which is in agreement with the occurrence of
an apoptotic process. In fact, 3-NP appears to activate the
mitochondrial pathway in cortical neurons by inducing cyto-
chrome c release. Recently, Galas et al. (2004) showed that
cytochrome c was released into the cytoplasm in cortical cultures
exposed to 0.1 mM 3-NP, although this release was not
associated with detectable caspase-3 activation. In the presence
of 1–3 mM 3-NP, caspases-2 and -8 were also activated,
suggesting the involvement of the extrinsic pathway, which has
been described to be dependent on the activation of death
receptors (Schulze-Osthoff et al., 1998). Thus, depending on the
concentration of 3-NP used, both apoptotic pathways could be
responsible for the processing and activation of the effector
caspase-3. Our results also suggested that, in the presence of
higher 3-NP concentrations (N1 mM), both apoptotic and necrotic
cell death occurred. This could be confirmed by the observation
that cytochrome c release, caspase-3 activation, or DNA
fragmentation were not further affected in the presence of 1–
3 mM 3-NP and by the fact that LDH leakage was significantly
increased. Furthermore, the analysis of the breakdown pattern of
fodrin, a sensitive substrate of both calpains and caspase-3,
showed a slight accumulation of the 145-kDa calpain-mediated
fodrin breakdown product only in the presence of 3 mM 3-NP.
These data suggest some activation of calpains, which are
normally associated with necrotic processes (Nasr et al., 2003;
Pang et al., 2003).
It has been shown that the elevation of intracellular calcium is
an early and important event in 3-NP-induced neuronal death
(Fukuda et al., 1998; Lee et al., 2002a). One of the consequences
of calcium entering into the cell is the activation of several
enzymes, namely, calcineurin. This calcium-dependent phospha-
tase has been described to be involved in many pathways that
ultimately lead to cell death (Asai et al., 1999; Springer et al.,
2000). Accordingly, inhibition of calcineurin as a relevant event in
FK506-mediated protective effects has been demonstrated by many
authors (Ankarcrona et al., 1996; Asai et al., 1999; Mobley and
Agrawal, 2003; Nishino et al., 1996; Stevens et al., 2003).
However, numerous other studies have excluded a substantial
contribution of inhibited calcineurin for neuroprotection exerted by
FK506 (Sabatini et al., 1997; Snyder et al., 1998; Toung et al.,
1999; Yardin et al., 1998). According to our data, this phosphatase
is only partially responsible for FK506-mediated neuroprotection
upon mitochondrial inhibition, since its activity was not completely
diminished in the presence of FK506. Furthermore, exposure to 3-
NP (0.3 mM) did not affect calcineurin activity. Therefore, we
cannot exclude a possible effect of FK506 independently of
calcineurin inhibition. Interestingly, we observed that neither 3-NP
(0.3 mM) nor FK506 was able to modify mitochondrial Bad levels,
reinforcing the hypothesis that calcineurin inhibition may not
determine the mechanism of neuroprotection induced by FK506. In
accordance, Galas et al. (2004) were unable to detect changes in
mitochondrial and cytosolic Bad upon exposure to 0.1 mM 3-NP in
cortical cultures.
In our study, FK506 interfered only with components of the
mitochondrial pathway. FK506 prevented the release of cyto-
chrome c from the mitochondria and caspase-3 activation induced
by low (0.1–0.3 mM) 3-NP concentrations. This protective effect
Fig. 6. FK506 decreases Bax levels and increases Bcl-2 levels in mitochondrial fractions. Cortical cultures were pretreated with 1 AM FK506 and then
incubated in the absence or in the presence of 0.3 mM 3-NP for 24 h. Mitochondrial (A, C, E) and total (B, D, F) fractions prepared from cortical neurons were
analyzed by SDS–PAGE followed by Western blot for Bad (A,B), Bax (C,D), and Bcl-2 (E,F). (Blots) Representative experiment from three to four different
experiments producing the same results. (Graphs) Densitometric analysis performed by normalizing Bcl-2 family proteins signals to the a-tubulin band. Data
were expressed as the meanF SEM of three to four different experiments. Statistical analysis: **P b 0.01, ***P b 0.001, compared to 3-NP-treated neurons in
the absence of FK506.
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morphology. In the presence of higher concentrations of 3-NP
(1–3 mM), FK506 was unable to prevent the activation of any
caspases tested or the number of cells displaying nuclear
fragmentation/condensation. FK506 also decreased Bax and
increased Bcl-2 in the mitochondria of 3-NP-treated cells. It is
well known that the Bcl-2 protein, which promotes cell survival,
acts by disrupting the formation of Bax homodimers that promote
cell death (Desagher and Martinou, 2000). Thus, the ratio of Bcl-
2 to Bax determines the survival or death of neurons following an
apoptotic stimulus. Therefore, the alterations in the levels of these
two proteins within the mitochondria could explain the protective
effect of FK506 downstream this organelle. In accordance with
this observation, we have previously demonstrated that over-
expression of Bcl-2 effectively protects against 3-NP-induced
toxicity (Brito et al., 2003).
Treatment with FK506 was previously shown to enhance
phospho-cAMP response element binding protein (pCREB)
immunoreactivity in hippocampal neurons and striatum slices
(Merlio et al., 1993). pCREB is known to mediate the
expression of a variety of genes, including brain-derived
neurotrophic factor (BDNF) (Beck et al., 1994), nerve growth
factor (NGF) (Tao et al., 1998), c-fos (Walton et al., 1996), andbcl-2 (Wilson et al., 1996). Although, FK506 has been described
to increase the transcription of the bcl-2 gene, it did not
significantly affect total Bcl-2 levels in cortical neurons treated
with 3-NP, suggesting no major modifications in the expression
of this protein. Thus, the protective effect of FK506 appears to
be mainly due to the alteration in the ratio of Bcl-2/Bax in the
mitochondria.
In conclusion, this study clearly demonstrates the protective
effect of FK506 in 3-NP-mediated apoptotic neuronal death and
suggests that this molecule may be used in neuroprotective
strategies against mitochondrial dysfunction occurring in Hunting-
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